Paper

Establishment of a pig influenza challenge model for evaluation of monoclonal antibody delivery platforms

Mcnee, Adam, Brown, Heather, Townsend, Alain, Smith, Trevor, Kash, John C, Fisher, Paul, Bessell, Emily, Ramos, Stephanie, Chrun, Tiphany, Xiao, Yongli, Rijal, Pramila, Schultheis, Katherine, Nunez, Alejandro, Clark, Becky, Beverley, Peter, Broderick, Kate, Guibinga, Ghiabe, Elliott, Sarah, Taubenberger, Jeffery K, Holzer, Barbara, Martini, Veronica, Bernard, Matthieu, Weiner, David, Patel, Ami, Tchilian, Elma

2020

Overview

Monoclonal antibodies are a possible adjunct to vaccination and drugs in treatment of influenza virus infection. However questions remain whether small animal models accurately predict efficacy in humans. We have established the pig, a large natural host animal for influenza, with many physiological similarities to humans, as a robust model for testing monoclonal antibodies. We show that a strongly neutralizing monoclonal antibody (2-12C) against the hemagglutinin head administered prophylactically at 15 mg/kg reduced viral load and lung pathology after pandemic H1N1 influenza challenge. A lower dose of 1 mg/kg of 2-12C or a DNA plasmid encoded version of 2-12C, reduced pathology and viral load in the lungs, but not viral shedding in nasal swabs. We propose that the pig influenza model will be useful for testing candidate monoclonal antibodies and emerging delivery platforms prior to human trials.

• Publisher: Cold Spring Harbor Laboratory Press,Cold Spring Harbor Laboratory
• Subject: Animal models / Hemagglutinins / Immunoglobulins / Immunology / Influenza / Monoclonal antibodies / Pandemics / Vaccination